相关实验视频

Updated: Jun 26, 2025

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model

Published on: April 3, 2016

放射性角膜切除术后20到30年会发生什么? 一系列案件系列案例系列

Yuri Iwamoto¹, Shizuka Koh, Ryota Inoue

¹Department of Ophthalmology (Y.I., S.K., N.M., K.N.), Osaka University Graduate School of Medicine, Osaka, Japan; Yodogawa Christian Hospital (Y.I.), Osaka, Japan; Department of Innovative Visual Science (S.K., R.I.), Osaka University Graduate School of Medicine, Osaka, Japan; SEED CO. (R.I.), LTD., Tokyo, Japan; and Department of Ophthalmology (M.M.), New York University Langone Medical Center, New York, NY.

Eye & contact lens

|May 10, 2024

概括

审查了放射性角质切割 (RK) 手术的结果. 许多RK后视力恶化的患者可以通过干预措施治疗,例如刚性气体透气隐形眼镜,尽管并非所有病例都可以治疗.

科学领域:

眼科医生眼科眼科
折射手术是一种折射手术.
角膜外科手术角膜外科手术

背景情况:

辐射角切除术 (RK) 是20世纪后期流行的一种折射手术程序.
长期的视觉结果和RK后并发症的管理是持续的临床兴趣.

研究的目的:

评估以前放射性角质切除术后视力恶化患者的折射校正和治疗干预措施的现状.

主要方法:

70名有RK病史的患者的回顾性图表审查.
对44名确定的患者的临床结果和干预措施的分析.

主要成果:

在RK后经历术后视力恶化的患者中,59%的患者可以进行折射或治疗干预.
刚性气体透性 (RGP) 隐形眼镜适用于不规则的眼是最常见的干预措施,在36%的适用病例中证明有效.

结论:

在RK后视力下降的患者中,很大一部分患者可以从RGP镜头等干预措施中受益.
管理策略对于治疗放射性角切割术后的长期视觉并发症至关重要,但并非所有病例都适合治疗.

更多相关视频

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis

Published on: November 12, 2015

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Regenerative Therapy by Suprachoroidal Cell Autograft in Dry Age-related Macular Degeneration: Preliminary In Vivo Report

Published on: February 12, 2018

相关概念视频